Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
BMJ Open|February 3, 2022
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationaleSimona de Portu, Linda Vorrink, Roseline Re, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 6, 2017
Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in SwedenJohan Jendle, Jayne Smith-Palmer, Alexis Delbaere, et al.
Pharmacological Research|January 13, 2006
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCAFrancesca Rossetti, Simona De Portu, Enrica Menditto, et al.
Diabetes Technology & Therapeutics|March 18, 2025
Automated Insulin Delivery Versus Standard of Care in the Management of People Living with Type 1 Diabetes and HbA1c <8%: A Cost-Utility Analysis in The NetherlandsErik H Serné, Maria Ida Buompensiere, Simona de Portu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 8, 2019
Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in FinlandStephané Roze, Jayne Smith-Palmer, Alexis Delbaere, et al.
Diabetes Technology & Therapeutics|September 12, 2019
Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in TurkeyStéphane Roze, Jayne Smith-Palmer, Simona de Portu, et al.
Diabetes Technology & Therapeutics|April 17, 2014
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methodsRonnie Aronson, Ohad Cohen, Ignacio Conget, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 26, 2019
Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the NetherlandsStephané Roze, Jayne Smith-Palmer, Simona de Portu, et al.
Diabetes Technology & Therapeutics|February 20, 2024
The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative ReviewChantal Mathieu, Waqas Ahmed, Pieter Gillard, et al.
Diabetes Technology & Therapeutics|December 10, 2015
Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in FranceStéphane Roze, Jayne Smith-Palmer, William Valentine, et al.
Pageof 5